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ated for predicting carditic events in Pts with recent chest pain (CP)(onsets
12 hours) (n= 33) or ongoingcp (n = 19) and nondiagnostic (Non Dx) ECG
in the Emergency Depaflment. Pts with acute/old Ml were excluded. Rest
Tc.SPECT (15-25 mCi) imaging was performed in 52 Pts, 50?4.males, mean
age 58 yrs (+ 14.9), who were hospitalized to “rule out Ml”. Of these 52 Pts,
rest 2D echo was performed in 39 Pts, 46% males, mean age 57 yrs (+
15,3). Primary end points were in hospital cardiac death, Ml, and emergency
PTCA/CABG. 2D echo, Tc.SPECTand end points were reviewed blinded. 43
Pta (83%) were event free. No Pt died; 9 Pts (17%) had events. 01 Pts with
NL2D echo, 2r28 (4%) had events. Of Pts with NLTc.SPECT, 3/24 (6Yo)had
events. Sensitivity for all events was 87% (2D echo and Tc.SPECT); speci-
ficity 82% (2D echo) and 50% (Tc.SPECT); negative predictive value 93%
(2D echo) and 88’%(Tc.SPECT), (p = ns). When 2D echo was performed or
Tetrofosmin was injected during CP,negative predictive value was 100%.
Corrc/usion:In Pts with recent or ongoing cpand a Non Dx ECG,acute2D
echo, when feasible, and Tc.SPECT are comparable techniques. 2D echo
and Tc.SPECT, when normal, may be powerful predictors of cardiac event
free hospitalization when performed during cp.
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n7571 No VariableOnTransesophagealEchocardiogrsphyPerformedat theTimeofStrokePredictsFuture
Strokeor Death:A ProspectiveStudy
J.M. Dent, R.A. Case, G. Kauffman, D. Nguyen, S. Kaul. University of
Virginia, Charlottesville, Virginia, USA
Many findings on transesophageal echocardiography (TEE) have been im-
plicated as causative of etroka without evidence for such causation. We
hypothesized that clinical risk factors, including previous stroke are the best
predictors of future stroke or death. Accordingly, 201 patients with stroke
prospectively underwent TEE, and were then followed for a mean of 2.5 +
1.2 yrs. Twelve patients died during initial hospitalization and 6 were lost to
follow-up. Of the remaining 183 patients, 35 had repeat strokes and 25 died
(total of 60 events, 33% over 2.5 yrs). On Cox regression analysis, none
of the findings on TEE predicted either repeat stroke or death. Clinical and
historical variables were the most important predictor of these eventa. For
repeat stroke, the positive predictors and their odds ratios were advanced
age (2.7), male gender (4.3), history of previous hypertension (5.9), and his-
tory of previous transient ischemic attack (3.8). For the occurrence of both
repeat stroke and death, the positive predictors and their odds ratios were
advanced age (2.7), male gender (2.4), and history of previous hypertension
(2.1), stroke (2.9), and diabetes (2.1). The prediotora that protected against
the occurrence of repeat stroke and their odds ratios were aspirin (-3.6) and
coumadin (-2.1) therapy. We conclude that strokes occur in patients with
traditional clinical rfskfactora, including histoy of previous transient ischemic
attacks. Subsequent mortality in thesepatientsis alsoaswciatedpositively
withtheseriakfactorsandnegativelywithaspirinandcoumadintherapy.In
lightof the poor predictivevalueof TEEfindingsfor subsequent stroke or
death, TEEshouldnotberoutinelyperformedinpatientswithstroke.
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n7572 Reletionof LeftAtrialAppandageFunction,ThrombusFormationandStrokeRiskinPatients
WithAtrialFibrillation:TheStrokePreventionin
AtrialFibrillation(SPAF)Ill Study
M.Zabelgoitia,forthe SPAFInvestigators.University of TexasHea/th
sCienCeCenter at San Antonio, San Antonio, TX, USA
Based on previously derived risk factors for stroke in pts with non-valvular
atrial fibrillation (AF)(femaleagez75yrs,syatolichypertension2160mmHg,
congestivehearffailure,or priorthrombeemboliam),387 high-riskand336
low-riskpts underwenttransesophagealachocardiography(TEE)at entry
intotheSPAF-111studyofantithrombdictherapy.Leftatrialappendage(LAA)
aize and function,spontaneousecho-contrast(SEC),and thrombuswere
prospectivelyasseased.
High-Risk(n= 387) Low-Risk(n= 336) p
Mean age (yrs) 71 67 0.001
Female (OA) 30 17 0.001
LAA SEC (“A) 64 47
Denss (%)
0,0001
21 6 0.0001
LAAthrombus(O/.) 10 4 0.001
LAAsize (cmz) 6,S + 2.9 6.4 & 2.7 0.07
LAAflowvelocities(crnlsac)
peak antegrade 33 i 22 38+ 25 o.ooa
peak retrogracls 35* 21 39* 24 0.006
mean antegrade 23* 19 26& 20 0.04
mean retrograde 22& 16 26& 16 0.01
In conclusion, TEE characteristics distinguish AFptsat high-riakforthrom-
boembolism. Higher LAA flow velocities in low-risk pts are aeeociated with
lees dense SEC and fewer thrombi, and may require less intense antithrom-
botic therapy.
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m7573 DoesMultilobularityof LeftAtrialAppendageRepreeentAnAdditionalRiskForThrombus
FormationinAtrialFlbrlllation?
D, Galzerano, B. Tucillo, D. Lama, G. Mirra, M. Giaei, M. Varricchio, J. Yao,
N. Masani, N. Pandian. Depavtmerrtof Geriatrics, // UnAfersify Napo/&ltai~
Cardiology”Division, N. Pellegrini Hospital, Afapoli, Italy, Tufts-New England
Medical Centec Boston, Massachusetts, USA
While left atrial appendage (LAA) is known to harbor clots in patiente (pta)
with atrial fibrillation (AF), it is not known whether LAA morphology influenzas
thrombue formation. Previous studies have shown that IAA is often multi-
Iobedand that multiplanartransesophageal achocardiography (MPTEE)aide
in visualizing additional lobes. Toassess whether the presence ofadditiona/
LAA /obes was associated with increased riak of thrombosis, we performed
MPTEE proepactively in 160 pts with non-valvular AF (age 41-80 yra, 93
malee). Based on MPTEE, pts were ditiided into multilobed LAA ((88/160,
42.5%, group ML) and single-lobed LAA (92/180, 57.5%, group SL) groupe.
In these groups we evaluated the following parameters: presence of throm-
bus in LAA or in IA, LA size, LAA size at base, LAA peak flow velocity, AF
duration and LVejection fraction (EF). Results (groups ML vs. SL, chisquare
test and Student t test).’Presence of thrombus 14/66, 20% vs. 8/92, 9% (p =
0.03); LAsize 48.4+ 5.2 vs. 49.1 & 6.9 mm (p = NS); LAA peak flow velocity
22.2 + 11.9 vs. 23.1 + 12.7 crnhec (p = NS); AFduration 5 + 3.evs. 4.8 + 4.1
months (p = NS); EF 44,3 + 8.6 vs. 43.1 & 7.9% (p = NS). This obaetvation
that muftilobed LAA is associated with increaeed incidence of LAA thrombus
suggeets that the presenceof a morecomplex morphological architecture of
LAA may facilitate thrombus formation and represent an additional riakfactor
for embolism.
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~1 Fan@SYVe.RaaliW: COmParin~PhYaiCiana Pre-TeSt
Probabilityto TransesophagealFindingain711
PatientsFromTheV.O.T.E.II Investigators
M.E.Goldman,M.Williame,M.McLaughlin,D. Katz,D.Goldberg,
B.Barzilai,D.Blanchard,R.Davidof,A. DeMaria,E.Fieher,S. Goldetein,
S. Homma,N.Pandian,S. Schwartz,M.Picard,C. Beffido,D.Bocardo,
E.Escudero,M. Metro,A. Gopal,L.Go,D.Vorchheimer,O. David,
P.Tunick,1.Kronzon,fortheV.O.T.E.II Study.Mount SirrairWdica/ CenteL
NY USA
In thecurrenteconomiccfimate,labexamsshouldprovidenewinforrnafion
not merelyconfirmphysicians’pre-testknowledge.Transeeophagealecho
(TEE)is an expensive,physicianintensive,invaeiveexam.To determine
howfrequentlyTEEprovidesnewinformation,the V.O.T.E.II etudyasked
referringMD’stheir pre-teetclinicaldiagnosis(dx) and probability(prob)
(high,medium,low)of thatdx beforeresultsof theTEEwereprovided.The
V.O.T.E.II study,an internationalconsortiumof tertiay referralinetitutione,
Pre TEE Pmb # New Conf New/Conf
High 41 .6% 56.7”A 28.3”/n 14.70/6
Med 32.3 70.4 23.9 5.6
Low 26,0 61.1 34.1 4,8
711 pt 62% 28.4% 9.3”/0
EMB 26.5”A 67.5 29,3 3.2
Endo 19.2 55.1 27,2 17.6
Valve 10.7 51.3 32.8 15.8
CHD 6.8 66,7 31.3 2.0
